Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000528615 | SCV000639369 | likely benign | Familial adenomatous polyposis 2 | 2023-10-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575298 | SCV000662602 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575298 | SCV000690618 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707728 | SCV000722244 | likely benign | not provided | 2019-03-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000609555 | SCV001361131 | likely benign | not specified | 2019-10-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575298 | SCV002532348 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-23 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000528615 | SCV004835259 | likely benign | Familial adenomatous polyposis 2 | 2024-02-05 | criteria provided, single submitter | clinical testing |